Affordable Access

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.

Authors
  • Verschraegen, C F
  • Levy, T
  • Kudelka, A P
  • Llerena, E
  • Ende, K
  • Freedman, R S
  • Edwards, C L
  • Hord, M
  • Steger, M
  • Kaplan, A L
  • Kieback, D
  • Fishman, A
  • Kavanagh, J J
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Feb 01, 1997
Volume
15
Issue
2
Pages
625–631
Identifiers
PMID: 9053486
Source
Medline
License
Unknown

Abstract

CPT-11 has significant activity in refractory cervical carcinoma. Gastrointestinal intolerance and hematologic toxicity must be monitored carefully. Further studies of alternative schedules may improve the tolerance and response rate.

Report this publication

Statistics

Seen <100 times